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PENANDA METABOLIK, TEKANAN OKSIDATIF DAN KERADANGAN 
DALAM KALANGAN WANITA DEWASA YANG TERDEDAH KEPADA 
ASAP ROKOK 
 
ABSTRAK  
Pengenalan: Pendedahan kepada asap rokok (perokok pasif) terjadi hasil daripada 
pembakaran rokok dan produk tembakau lain dan dari hembusan asap rokok oleh 
perokok. Kebanyakan kematian dan morbiditi yang disebabkan oleh pendedahan 
kepada asap rokok dalam kalangan orang dewasa adalah berkaitan dengan penyakit 
kardiovaskular.  
Objektif: Kajian ini bertujuan untuk menentukan kesan pendedahan asap rokok pada 
penanda metabolik, tekanan oksidatif dan keradangan pada wanita dewasa yang 
sihat. 
Metodologi: Kajian ini adalah kajian perbandingan secara keratan-rentas di antara 
101 melaporkan diri sebagai perokok pasif dan 91 bukan perokok pasif dalam 
kalangan wanita yang tiada mempunyai sejarah klinikal penyakit kardiovaskular. 
Perokok pasif didefinisikan sebagai pendedahan kepada asap rokok selama sekurang-
kurangnya 15 minit dalam 2 hari dalam tempoh seminggu, manakala bukan perokok 
pasif didefinasikan bebas daripada terdedah kepada asap rokok. Sampel darah 
diambil daripada kesemua peserta yang layak untuk mengukur kadar penanda 
metabolik (HMW adiponektin, insulin, HOMA-IR dan NEFA), tekanan oksidatif 
(LDL teroksida dan 8-isoprostane) dan hsCRP sebagai penanda keradangan. Analisis 
nikotin pada rambut dijalankan untuk mengesahkan status pendedahan pada peserta. 
Hasil kajian: Tahap nikotin pada rambut adalah lebih tinggi pada kumpulan perokok 
pasif berbanding dengan bukan perokok pasif [0.22 (0.62) vs 0.04 (0.11) ng / mg; p = 
xiv 
 
0.009]. Tiada perbezaan yang signifikan pada HMW adiponektin, insulin dan 
rintangan insulin (HOMA-IR), 8-isoprostane, LDL teroksida dan NEFA di antara 
kedua-dua kumpulan perokok pasif dan bukan perokok pasif dalam kalangan wanita 
dewasa, walaupun selepas mengawal beberapa faktor perancu yang berpotensi. 
Serum HMW adiponektin berkait secara negatif dengan tahap insulin dan rintangan 
insulin (HOMA-IR). Tiada perkaitan yang signifikan dilihat di antara HMW 
adiponectin dan NEFA, 8-isoprostane, LDL teroksida dan hsCRP pada wanita yang 
terdedah kepada asap rokok. 
Kesimpulan: Penemuan kami menunjukkan bahawa pendedahan kepada asap rokok 
tidak memberi sebarang kesan terhadap penanda metabolisme, tekanan oksidatif dan 
keradangan dalam kalangan wanita dewasa yang sihat. Penurunan serum HWM 
adiponektin adalah berkaitan dengan peningkatan insulin dan rintangan insulin dalam 
kalangan mereka yang terdedah kepada asap rokok. 
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METABOLIC, OXIDATIVE STRESS AND INFLAMMATORY MARKERS 
IN ADULT WOMEN EXPOSED TO SECONDHAND SMOKE 
 
ABSTRACT 
Introduction: Secondhand smoke (SHS) is formed from the burning of cigarettes 
and other tobacco products and from smoke exhaled by smokers. Most of the 
mortality and morbidity attributable to exposure of adults to SHS is related to 
cardiovascular diseases.    
Objectives: This study aims to determine the effects of SHS exposure on metabolic, 
oxidative stress and inflammatory markers in healthy adult women.  
Methods: This is a comparative cross-sectional study between the group of self-
reported SHS (n=101) and non-SHS exposure (n=91) in healthy women without 
clinical evidence of cardiovascular disease. Exposure to SHS is defined as exposed to 
secondhand smoke for at least 15 minutes in 2 days within a week, while non-SHS is 
people not exposed to SHS. Blood was drawn from all eligible subjects to measure 
metabolic (High molecular weight (HMW) adiponectin, insulin, homeostasis model 
assessment (HOMA-IR) and non-estrified fatty acids (NEFA), oxidative stress 
(oxidized low density lipoprotein (oxidized LDL) and 8-isoprostane) and 
inflammatory (hsCRP) markers. Hair nicotine analysis was performed to validate the 
exposure status in subjects. 
Results: Hair nicotine levels were significantly higher in SHS exposure group 
compared to non-SHS exposure group [0.22 (0.62) vs. 0.04 (0.11) ng/mg; p=0.009]. 
No significant differences were observed in HMW adiponectin, insulin and insulin 
resistance (HOMA-IR), NEFA, 8-isoprostane, oxidized LDL and hsCRP between the 
two groups, even after controlling for several potential confounders.  Serum HMW 
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adiponectin was negatively correlated with insulin level and insulin resistance 
(HOMA-IR) in the group of women exposed to SHS. No significant correlation was 
seen between HMW adiponectin and NEFA, 8-isoprostane, oxidized LDL and 
hsCRP in SHS women.   
Conclusion: This study did not show any significant differences in metabolic, 
oxidative stress and inflammatory markers in healthy adult women exposed and non-
exposed to SHS. Low serum HWM adiponectin is associated with increased insulin 
level and resistance in SHS exposed women. 
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CHAPTER ONE 
 
 
 
INTRODUCTION 
 
 
Secondhand smoke is also called as environmental tobacco smoke (ETS) or 
passive smoke, is produced from the sidestream smoke that released into the 
environment from the burning end of a cigarettes or other tobacco products, and 
from the mainstream smoke which is smoke exhaled by the smoker (WHO, 2010a). 
Evidence indicates that SHS leads to coronary heart disease (CHD) in adults (U.S. 
Department of Health Human Services, 1986). Moreover, it has been estimated that 
about 46,000 cardiac deaths are attributable to SHS exposure in the United States 
(California Environmental Protection Agency, 2005). Around the world, it has been 
shown that about one third of adults are regularly exposed to tobacco smoke (WHO, 
2010a). Whereas, in Malaysia, approximately 40% adults are exposed to SHS at 
home and workplace, while 71% adults are exposed to SHS inside of restaurants 
(WHO, 2011).  
There are approximately 7000 chemicals found in cigarette smoke that are 
liberated as gases, vapours and particles during combustion (Öberg et al., 2010a). 
Many crucial responses of the cardiovascular system are very sensitive to the toxins 
in SHS (Barnoya and Glantz, 2005). For example, prior study demonstrated that free 
radicals contained in cigarette smoke decreased the release of nitric oxide from the 
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endothelium and enhanced the production of highly reactive intermediates, hence 
causing endothelial injury (Jaimes et al., 2004). The chemical toxicity present in 
SHS exerts adverse effects on cardiovascular system such as platelet activation, 
increased oxidative stress, inflammation, increased insulin resistance, endothelial 
dysfunction, increased arterial stiffness, atherosclerosis, increased risk of coronary 
disease events and decreased energy metabolism (Barnoya and Glantz, 2005). 
Nicotine is one of the important elements present in large amounts in the 
cigarette smoke, forming approximately 7-8 mg per cigarette (IARC, 2004). 
Atmospheric concentration of nicotine is identified as a sensitive and specific 
indicator for SHS (U.S. Department of Health and Human Services, 2006a). 
Recently, hair nicotine biomarker has been used as a validated indicator for SHS 
exposure (Al-Delaimy et al., 2002, Woodruff et al., 2003, Avila-Tang et al., 2012). 
Moreover, hair nicotine has been recommended by several studies as a potential 
marker of long-term exposure to cigarette smoke (Al-Delaimy, 2002, Pichini et al., 
1997) 
Adiponectin is a beneficial protein secreted by white adipose tissue and its 
function is important in lipid and glucose metabolism. The protein of adiponectin 
exists in plasma in three forms; low molecular weight (LMW) form is adiponectin 
trimmer, medium molecular weight (MMW) is hexamer  and high molecular weight 
(HMW) is a complex form of adiponectins (Waki et al., 2003). Total adiponectin 
measurement comprises these three forms which include LMW, MMW and HMW 
adiponectin (Beltowski et al., 2008). Studies suggested that HMW adiponectin form 
may be the most biologically active form and represent a better marker for metabolic 
syndrome and insulin resistance than total adiponectin (Hara et al., 2006, Nakano et 
al., 2006). In contrast to other adipocytokines, low levels of adiponectin have been 
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related with cardiovascular disease (CVD) risk factors including obesity and type 2 
diabetes (T2D) (Arita et al., 1999, Hotta et al., 2000, Weyer et al., 2001). To our 
knowledge, there are no studies available that examined the effects of SHS exposure 
on HMW adiponectin concentration in women. However, among both healthy 
subjects and diseased patients, adiponectin levels are lower in active smokers 
compared to non-smokers (Takefuji et al., 2007, Miyazaki et al., 2003, Iwashima et 
al., 2005).  
Insulin resistance is defined as a reduced response of tissues (such as the 
skeletal muscle, liver, and adipocytes) to the insulin action in transporting glucose 
(DeFronzo and Tripathy, 2009). Persons with insulin resistance generally have 
elevated glucose and insulin levels in their blood at the same time (NIDDK, 2008). 
Insulin resistance is not simply a complication of impaired glucose uptake in 
response to insulin, but a multifaceted syndrome that raises significantly the risk for 
CVD (Ginsberg, 2000). Furthermore, a prior study also found that women with SHS 
exposure are associated with low insulin sensitivity (Henkin et al., 1999).  
Non-esterified fatty acids (NEFA) or also known as free fatty acids (FFA) are 
a marker for the lipolysis effects (lipid mobilization). NEFA is important in 
modulating insulin and has  good correlation with insulin resistance (Eliasson et al., 
1994). Previous studies reported that increase in NEFA levels are associated with 
diabetes (Wilding, 2007) and sudden death in middle-aged men (Jouven et al., 2001). 
Kershbaum et al revealed that smoking elevates the levels of NEFA in active 
smokers (Kershbaum et al., 1961). However, so far no study examined the effect of 
SHS exposure on NEFA levels. 
Free radicals from tobacco smoke may promote oxidative stress by 
promoting the generation of reactive oxygen species through enhancing 
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inflammatory cells activation (Burke and Fitzgerald, 2003). Oxidative stress is a 
disruption in the balance between reactive oxygen species generation and 
endogenous antioxidant defences, thereby resulting to oxidation of lipids, proteins, 
and DNA in ways that decrease cellular function (Burke and Fitzgerald, 2003).  8-
isoprostane or F2-isoprostane is an important oxidative stress marker, comprised of 
prostaglandin-like compounds which are derived from arachidonic acid via lipid 
peroxidation (Morrow et al., 1990). 8-isoprostane is shown to be increased in 
diabetes (Sampson et al., 2002), hypertension (Hozawa et al., 2004), obesity (Davi et 
al., 2002), atherosclerosis (Oguogho and Sinzinger, 2000) as well as in cigarette 
smoking (Morrow et al., 1995). Besides, oxidation of low-density lipoprotein (LDL) 
from native form into oxidized form (oxidized LDL) plays a significant role in the 
pathogenesis of atherosclerosis (Yoshida and Kisugi, 2010). Evidence suggests that 
smoking significantly increased oxidized LDL levels in men (Linna et al., 2008). 
Moreover, exposure to SHS in non-smokers is related with the elevated levels of 
oxidized LDL (Panagiotakos et al., 2004b) and 8-isoprostane (Kato et al., 2006b). 
Inflammation is important in mediating atherosclerosis formation and 
progression in the circulatory system (Libby et al., 2002). C-reactive protein (CRP) 
is an acute phase plasma protein that synthesised in the liver in response to general 
inflammatory episodes within the body. Serum CRP levels have been used as a 
predictive marker for determining CVD risk (Tonstad and Cowan, 2009). Study has 
shown that a high CRP concentration is associated with risk of CVD in women 
(Bermudez et al., 2002). Prior studies also showed, CRP levels were significantly 
higher in people who reported exposure to SHS than those whose were non-exposed 
and low SHS exposure (Panagiotakos et al., 2004b, Hamer et al., 2010). 
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Importance of study 
The use of tobacco is the most important preventable cause of disease and 
death in the world today (WHO, 2008b). Globally, about 12% of all deaths in adults 
aged above 30 years are attributable to tobacco (WHO, 2012). Smoking prevalence 
is extremely high, especially among men. In Malaysia, almost 43.9% of men smoke 
(WHO, 2011). An increase in number of smokers definitely increased the prevalence 
of SHS exposure, especially among women and children. In Malaysia it is difficult to 
avoid exposure to cigarette smoke even in non-smoking areas such as airports, 
restaurants, mosques, schools or hospitals. In addition, there is also no law in placed 
to protect women and children from SHS exposure in the home. Although there is an 
awareness of the danger of SHS exposure in adults (WHO, 2011), but it is pointless 
if smokers still ignored it. Furthermore, active smokers inhaled only 15% from the 
entire cigarette smoke, while the remaining 85% of smoke is usually liberated into 
the surroundings, thus inhaled by people around the smokers (Division of 
Periodontology, 2003).  
Majority of smokers in Malaysia are among the Malay ethnic group (27.9%) 
followed by Chinese (19.2%) and Indians (16.2%) (Tarmizi et al., 2007). About 
55.6% of children (aged 10-12 years) from Kota Bharu were reported to be living 
together with at least one smoker, particularly their father at home (Sharina, 2007). 
This shows that it is a serious phenomenon that needs to addressed in order to protect 
never smokers from the health risk of SHS exposure. 
Metabolic, inflammatory and oxidative stress contribute to increased CVD 
risk. Subjects with SHS exposure also have increased risk for diabetes mellitus. So 
far, there are no studies on the chronic effects of SHS exposure to the metabolic 
markers NEFA and HMW adiponectin. There is also no large study that measures 
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the biomarkers of oxidative stress, inflammatory and metabolic markers among SHS 
exposed subjects and women in one single study. A study that simultaneously 
measures these parameters in a single study would be valuable in giving information 
to understand more about the mechanisms whereby secondhand smoke exposure 
contributes towards increasing the risk for CVD. This knowledge would be useful to 
educate the population, specifically smokers and SHS exposed individuals, and to 
institute preventive measures to prevent CVD complications from exposure to SHS.  
 
General objective 
To determine the effects of secondhand smoke exposure on metabolic, oxidative 
stress and inflammatory markers in healthy adult women.  
 
Specific objectives 
1. To compare serum HWM adiponectin levels in SHS and non-SHS women. 
2. To compare serum insulin levels and insulin resistance (HOMA-IR) in SHS 
and non-SHS women.  
3. To compare serum non-esterified fatty acid (NEFA) levels in SHS and non-
SHS women. 
4. To compare the oxidative stress markers (serum 8-isoprostane and oxidized 
LDL levels) in SHS and non-SHS women.  
5. To compare inflammatory marker of plasma high sensitive C-reactive protein 
levels in SHS and non-SHS women.  
6. To examine the relationship between HMW adiponectin and insulin, insulin 
resistance (HOMA-IR), NEFA, 8-isoprostane, oxidized LDL and hsCRP in 
the group of women with SHS exposure. 
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Hypothesis  
1. Serum HMW adiponectin levels are lower in SHS women compared to non-
SHS. 
2. Serum insulin and insulin resistance (HOMA-IR) levels are higher in SHS 
women compared to non-SHS. 
3. The serum of non-esterifies fatty acid (NEFA) is higher in SHS women 
compared to non-SHS.  
4. Oxidative stress markers (both serum 8-isoprostane and oxidized LDL) are 
higher in SHS women compared to non-SHS. 
5. Inflammatory marker of plasma high sensitive C-Reactive protein (hsCRP) is 
higher in SHS women compared to non-SHS. 
7. HMW adiponectin is negatively associated with insulin, insulin resistance 
(HOMA-IR), NEFA, oxidative stress markers (8-isoprostane and oxidized 
LDL) and inflammatory marker (hsCRP) in the group of women exposed to 
SHS. 
 
Operational definition  
Secondhand smoke (SHS) exposure is defined as exposure to secondhand smoke for 
at least 15 minutes in 2 days within a week (WHO, 1986). Non-SHS is defined as 
people who are free from SHS exposure. 
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CHAPTER TWO 
 
 
 
LITERATURE REVIEW 
 
 
2.1 Secondhand smoke exposure  
2.1.1 Definition of secondhand smoke exposure  
Secondhand smoke (SHS) exposure or passive smoking is formed from the 
sidestream smoke and mainstream smoke from cigarette smoking. Sidestream smoke 
is smoke that is liberated into the surroundings from smouldering cigarette between 
puffs (primary contributor to SHS) and mainstream smoke is smoke that is exhaled 
by smokers (Öberg et al., 2010a). Elements in sidestream smoke is more toxic 
compared to element contained in mainstream smoke (Öberg et al., 2010a). 
Moreover, sidestream smoke have greater concentration of the most toxins contained 
in tobacco smoke than mainstream smoke, may be because sidestream smoke is 
produced at lower temperatures and with dissimilar burning conditions compared to 
mainstream smoke (U.S. Department of Health Human Services, 1986). The 
complex reactive substances contained in tobacco smoke are usually liberated as 
gases, vapors and particles during combustion (Öberg et al., 2010a). The United 
States National Toxicology Program identified about 250 constituent found in SHS 
are toxic or carcinogenic (U.S. Department of Health and Human Services, 2006a). 
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Apart from the terms secondhand smoke, “environmental tobacco smoke” or 
“passive smoking” or involuntary smoking” are also frequently used in studies to 
describe tobacco smoke exposure. The terms “secondhand” reflects the involuntary 
nature of the exposure. This study uses the term secondhand smoke following the 
official position from the Tobacco Free Initiative (Öberg et al., 2010a). Moreover, 
the term “environmental” reflects more  on ambient pollutant which is not 
specifically caused by smoking but can be contributed by other pollutant such as 
those emitted from factories and vehicles such as lorry and cars. Furthermore, 
exposure to cigarette smoke may happen in various locations, such as at home, 
workplace, public place and in car.  
The SHS exposure definition of at least 15 minutes in 2 days within a week 
exposure that was used in this study originated from World Health Organization 
(WHO) (1986). Nearly similar definition as ours has been applied in several 
epidemiological studies (Yang et al., 1999, Samet and Yang, 2001, Yang et al., 
2010, Panagiotakos et al., 2004b, Nor et al., 2008).  For example, in China they 
demonstrated that SHS exposure for at least 15 minutes daily for more than one day 
every week were well-correlated with hair nicotine concentration among women 
exposed to SHS at home (Yang et al., 2010).  
 
2.1.2 Prevalence of secondhand smoke exposure  
In the United States, exposure to SHS remains a serious public health hazard, 
although progress has been made to protect non-smokers (U.S. Department of Health 
and Human Services, 2006a). A Global Adult Tobacco Survey (GATS) Malaysia 
2011 was conducted among persons age 15 and above reported that about half of 
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non-smokers in this study were exposed to SHS in their homes, while 70.3% non-
smokers reported exposed to SHS in public places (Ministry of Health, 2003).  
Across the globe, men are the biggest tobacco user (Shafey, 2009). For 
example, in Malaysia, it is estimated that about 43.9% of men and 1.0% of women 
are currently smoking (WHO, 2011). In China, smoking prevalence rates for men 
and women were 63% and 3.8%, respectively (Yang et al., 1999). In developed 
countries, however, smoking among men and women are nearly equal which is about 
32% and 18%, respectively (Shafey, 2009). High prevalence of smoking among men 
placed women and children at the risk for SHS exposure especially in developing 
countries (Gilmore et al., 2004). A survey in China showed that prevalence of SHS 
exposure were much higher in women rather than in men (Yang et al., 1999, Gu et 
al., 2004). However, in high income country such as Spain, exposure prevalence rate 
is similar, with 70% for men and 63% for women (Twose et al., 2007).  
Home and workplace are classified as predominant places for SHS exposure 
in the United States (U.S. Department of Health and Human Services, 2006a). 
According to several surveys conducted in Malaysia, it is estimated that 78% smokers 
smoked in the homes (Wipfli et al., 2008). Another survey in Malaysia also indicated 
that 33.3% women were exposed to SHS at home (WHO, 2011). Furthermore, 
Marbury et al. (1993) showed that concentration of ambient nicotine in the homes 
where smoking is restricted were lower than that in the homes where smoking is 
allowed (Marbury et al., 1993).  According to a probe on the behaviour of smoking 
among spouses at home, a report indicated that the level of hair nicotine in women 
whose spouses smoked at home is higher compared to women with non-smoking 
spouses. Moreover, no difference was reported in hair nicotine level between the 
group of women whose spouses were smoking outside the home versus those with 
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spouses smoking inside the home (Yoo et al., 2010). Another report shows that the 
increase in serum cotinine level is in parallel with an increase in the number of 
tobacco smoked by smokers at home (Nondahl et al., 2005).  
Workplaces also has been identified as primary contributor to SHS exposure 
(Perez-Rios et al., 2012). United States’ workers reported to have higher exposure to 
SHS in workplaces rather than at home (Hammond, 1999). A survey conducted in 
Malaysia estimated that 30.1% women had SHS exposure at workplace during the 
past 30 days (WHO, 2011). The highest prevalence of SHS exposure in the 
workplace was in southern and central Europe (Janson et al., 2001). Serum cotinine 
levels in non-smoking workers have been identified to increase with increased hours 
per day of SHS exposure at workplace; 0 h/day exposure (0.08 ng/mL), <1 h/day of 
exposure (0.18 ng/mL), 1-4 h/day of exposure (0.34 ng/mL) and >4 h/day of 
exposure (0.30 ng/mL) (Nondahl et al., 2005). Even though the ventilation systems 
was used inside the buildings to minimize soiled air, it is identified as incapable to 
completely remove the hazardous compounds from the smoke (Kotzias et al., 2006). 
Exposure in the car or other public places is also a crucial source of SHS 
exposure. About 38% students reported having been exposed to cigarette smoke in 
the car over the last 7 days (Wolfson et al., 2009). Concentration of nicotine in 
confined spaces such as cars also can be higher (Danzon et al., 2000). Restaurants 
are also  important locations for contributing to SHS exposure in women.According 
to the Global Adult Tobacco Survey among 5112 households in Malaysia, 68.4% 
adult women were exposed to SHS in restaurants over the past 30 days (WHO, 
2011).  
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2.1.3 Implications of secondhand smoke exposure 
Based on scientific evidence, WHO Framework Convention on Tobacco 
Control established an articulation that SHS exposure can cause death, disease and 
disability, and there is no safe level of SHS exposure (U.S. Department of Health and 
Human Services, 2006a). It was estimated that about 603 000 deaths were caused by 
SHS worldwide and ischaemic heart disease has been recorded as the highest 
contributor to mortality among adults caused by SHS exposure (Öberg et al., 2010b). 
Besides, more than 79,000 adults die each year as a result of SHS in the 25 European 
countries (Jamrozik, 2006).  
Cardiovascular disease (CVD) is the major contributor for morbidity and 
mortality among Malaysian women. The deaths caused by CVD among Malaysian 
female patients in the government hospitals remained constant over 7 years (from 
1999 to 2006) (MOH, 2008). In the United States, cardiovascular-related medical 
care is more costly compared to any other diseases (NIH, 2011), whilst, for 
developing country particularly Malaysia it gives a huge economic burden to health 
sector. Thus, it is necessary to identify the risk factors contributing to CVD in people 
who have been exposed to SHS (Glantz and Parmley, 1991, He et al., 1999). 
During the past two decades, studies reported evidence concerning SHS 
exposure and CVD risk factors and other health implications including CHD (U.S. 
Department of Health, 1972, He et al., 1999, Steenland, 1992, U.S. Public Health 
Service, 1983), atherosclerosis (Yuan et al., 2007, Nagel et al., 2009) and lung 
cancer (U.S. Department of Health and Human Services, 2006b). The effect of even 
a short SHS exposure on the cardiovascular system could reach around 80 to 90% as 
in chronic active smoking (Barnoya and Glantz, 2005). In children, SHS exposure 
can cause respiratory symptoms (Sharina, 2007). Although smoke inhaled by a 
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person with SHS exposure is much less than smoke inhaled by smokers, but it 
increases the risk of CHD by approximately 30% (Barnoya and Glantz, 2005). 
Regrettably, the risks associated with SHS exposure were not as often reported as 
compared to risks associated with active smokers. 
 
2.2 Nicotine exposure  
Nicotine is a chemical constituent that is present in tobacco and has a mild 
stimulant and relaxing effects to smokers. Nicotine acts by affecting the sympathetic 
nervous systems and adrenal glands, which enhances releasing epinephrine and 
norepinephrine (Yusoff, 2010). In addition, nicotine also acts on human adipose 
tissue, where it is previously demonstrated that incubation of mouse adiposities 
media culture with nicotine caused reduction in secretion of adiponectin into the 
media (Iwashima et al., 2005). Nicotine is released from sidestream smoke particle 
and evaporates as soon as it is diluted into ambient, and it is found highly 
concentrated (919 µg per cigarette) in sidestream cigarettes smoke (Fowles et al., 
2000). Nicotine has been identified as a specific to cigarette combustion and is 
present in high amount in SHS. Hence, nicotine is appropriate to be used as an 
indicator for SHS (U.S. Environmental Protection Agency, 1992). Nicotine in the 
blood has a relatively short half-life (2 hours), hence blood nicotine level is suitable 
to use as an indicator for exposure during the prior hours. Recently hair nicotine has 
been measured as a reliable biomarker for SHS exposure over the previous 1-2 
months (Öberg et al., 2010a). Over the past several years, nicotine measurement has 
been used extensively as a reasonably sensitive biomarker indicative of exposure to 
SHS exposure in various population studies (Man et al., 2009, Al-Delaimy et al., 
2002, Al-Delaimy et al., 2000, Woodruff et al., 2003). 
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Previously urine cotinine is widely used to measure SHS exposure and has 
been recommended as the “gold standard” biomarker of SHS exposure. However this 
biomarker has a relatively short half life of 20 hours and it is easily affected by inter-
individual variability in cotinine excretion levels for identical exposures (Al-Delaimy 
et al., 2002). Therefore, the more recent method has been developed to measure 
nicotine in the hair. Hair nicotine is less affected by the daily fluctuation of SHS 
exposure because hair has a slow growth rate. Moreover, the hair nicotine levels can 
provide a long term exposure history because each one centimetre (cm) of hair is 
equivalent to about one month’s exposure (Al-Delaimy et al., 2002, Uematsu et al., 
1995). Hair nicotine concentration reflects the amount of nicotine accumulated in the 
hair and it is sustained in the hair shaft throughout the hair life. Nicotine assembles 
in the hair mainly by direct absorption from the environment (Eisner et al., 2005). 
Report revealed that hair nicotine concentration is linearly associated  with the 
duration and concentration of exposure to ambient nicotine (Eliopoulos et al., 1994). 
Advantages of doing hair nicotine assay is hair sample is easy for sample collection, 
inexpensive for storage and transport, less variability and capable to describe the 
exposure over a long-term period compared to other biological samples. Moreover, 
hair nicotine shows a better correlation with variables of reporting SHS exposure 
than urine cotinine levels (Al-Delaimy et al., 2002).  
Kim et al. (2009) demonstrated that women exposed to SHS have higher 
levels of hair nicotine than those who were non-exposed (Kim et al., 2009). 
Moreover, women from Asia who lived together with household smokers showed the 
highest hair nicotine levels compared to women from Europe and Latin America 
living with smokers at home (Wipfli et al., 2008).  
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2.3 Cardiovascular biomarkers  
2.3.1 High molecular weight adiponectin  
Adiponectin is a beneficial protein that is released abundantly from white 
adipose tissue (Hotta et al., 2001). Adiponectin is also known as ACRP30 (Scherer 
et al., 1995), AdipoQ (Hu et al., 1996) or gelatine-binding protein-28 (Nakano et al., 
1996). It consists of 247 amino acids and four domains; an amino-terminal signal 
sequence, a variable region, a collagen region and a carboxyl-terminal global region. 
Adiponectin is regulated by an autocrine or paracrine manner and endocrine manner 
within distal tissue. According to Arita et al., (1999), plasma adiponectin is  
abundantly present in healthy subjects ranging from  1900 to 17000 µg/ml (Arita et 
al., 1999). In contrast to other adipocytokines that are higher in obesity, adiponectin 
is significantly decreased in obese compared to lean subjects. Adiponectin  is 
beneficial in several activities such as increasing insulin sensitivity, stimulating fatty 
acid oxidation, inhibiting inflammatory reaction and inducing endothelium-
dependent nitric oxide-mediated vasorelaxation (Beltowski et al., 2008). In addition, 
adiponection level is also reported to be low in cases of metabolic syndrome (Hara et 
al., 2006, Matsushita et al., 2006), T2D (Zhu et al., 2010, Almeda-Valdes et al., 
2010) and arteriosclerosis (Ouchi et al., 2001, Matsuda et al., 2002). A study 
suggested that the rise of adiponectin concentration may be a useful novel 
therapeutic strategy in a number of CVD. Because, adiponectin has a protective role 
in some cardiovascular pathologies including endothelial dysfunction, atherogenesis, 
myocardial ischemia-reperfusion injury and myocardial hypertrophy. Deficiency of 
this protein may contribute to complications in patients with metabolic syndrome 
(Beltowski et al., 2008).  
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Adiponectin level is relatively 65% greater in women compared in men 
(8.0±4.5 µg/ml vs. 4.9±2.6 µg/ml; p<0.001) (Ahonen et al., 2008, Kern et al., 2003). 
Lower adiponectin in men may be related to divergence in fat distribution and higher 
testosterone levels. Men have more visceral fat and less subcutaneous fat compared 
to women (Matsushita et al., 2014, Ludescher et al., 2007). Adiponectin is mainly 
synthesized in subcutaneous fat cells in adipose tissues. Moreover, testosterone in 
men inhibits secretion of adiponectin from fat cells (Xu et al., 2005). On the other 
hand, adiponectin was negatively associated with BMI, where increased in weight 
reflects to the accumulation of visceral fat that causes for insulin resistance and 
inflammation, this could reduce adiponectin level (Kern et al., 2003, Komatsu et al., 
2012, Krakoff et al., 2003).  
Adiponectin exists in adipocytes and plasma in three different forms, low-
molecular weight (LMW) adiponectin (three native molecules connected hydrogen 
bonds between their globular domains), medium-molecular weight complexes 
(MMW) adiponectin (2 trimers connected with the disulfide bond between Cys22 
residues) and high-molecular weight forms (HMW) adiponectin (non-covalently 
bound 2 or 3 hexamers contain 12 or 18 single monomer molecules) (Waki et al., 
2003). Quantifying LMW, MMW and HMW by gel filtration sub-fractionation 
accounted for approximately 20%, 34% and 46%, respectively in serum (Lo et al., 
2011). Different forms of adiponectin varies in biological function, however studies 
suggested that HMW adiponectin complex is the most active form of adiponectin 
because it has the ability to reduce blood glucose (Pajvani et al., 2004).  
A number of studies have suggested that HMW adiponectin is the best 
marker to determine adiponectin rather than total adiponectin (comprise of LMW, 
MMW and HMW protein complexes). Previous studies revealed that HMW 
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adiponectins have a greater statistical power for diabetes estimation (Hara et al., 
2006, Seino et al., 2007, Heidemann et al., 2008, Nakashima et al., 2006), coronary 
artery disease (Aso et al., 2006), and metabolic syndrome (Hara et al., 2006, Seino et 
al., 2007) than total adiponectin. Hence, evaluations of HMW adiponectin is likely 
more relevant in determining and evaluating CVD mechanisms than total 
adiponectin. 
Recently, an ELISA specific monoclonal antibody system was developed to 
quantify human HMW adiponectin (Nakano et al., 2006). ELISA is more affordable 
and less time consuming compared to using western blotting (Arita et al., 1999) or 
gel filtration chromatography (Aso et al., 2006), which is more expensive and 
difficult to perform in large population studies.  
Smoking inhibits adiponectin in healthy subjects and in patients with chronic 
disease (Takefuji et al., 2007, Miyazaki et al., 2003, Iwashima et al., 2005). 
Adiponectin is significantly lower in active smokers compared to non-smokers 
(Iwashima et al., 2005, Takefuji et al., 2007). Furthermore, heavy smokers (smoking 
more than 25 cigarettes per day) have a lower adiponectin level compared to 
moderate and light smokers even after the age, BMI, alcohol intake, physical activity 
and total calorie intake were controlled (Takefuji et al., 2007). Adiponectin was 
found to be inversely associated with Brinkman index (number of cigarettes smoked 
per day X number of years of the habit) in current smokers (Miyazaki et al., 2003). 
Iwashima et. al., (2005) demonstrated that 12 hours of acute smoking exposure in 
healthy non-smokers markedly reduced adiponectin level. Besides, a laboratory 
experiment showed that incubation of adipocytes cell culture with nicotine decreased 
the mRNA (messenger ribonucleic acid) expression and secretion of adiponectin 
(Iwashima et al., 2005). A study revealed that heavy smokers have the lowest level 
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of serum HMW adiponectin levels compared to non-smokers in the group of subject 
with high insulin resistance (subjects with age ≥ 60 years, BMI ≥ 22 kg/m2 and 
HOMA-IR ≥ 1.6) (Kawamoto et al., 2010).  However, there are contradictory results 
arise, where one study reported no difference in HMW adiponectin levels between 
current smokers and non-smokers among Japanese male subjects who have normal 
glucose tolerance (Watanabe et al., 2011). This contradictory finding between 
Kawamoto et al. and Watanabe et al. may be because the difference in subject 
population, where subjects from Kawamoto’s study have higher insulin resistance 
compared to subjects in Watanabe’s study with mean of HOMA-IR was 0.90 ± 0.18. 
This suggests that low levels of HMW adiponectin in smokers may be related to 
insulin resistance response, since insulin resistance is increased in smokers compared 
to non-smokers (Facchini et al., 1992, Abbasi et al., 2006).  
 
2.3.2 Insulin 
Insulin was recognized in the early 1920’s as the major hypoglycaemic 
hormone (Kumar and O'Rahilly, 2005). Insulin is produced in the islets of 
Langerhans with a molecular weight of 5808 Da and consists of 51 amino acid 
(Srinivasa Nageswara Rao et al., 2011). Insulin is generated from proinsulin through 
the action of tryptic and carboxypeptidaselike enzymes. Proinsulin is a single 
polypeptide chain comprised with subunits of insulin joined by the C-peptide region 
(Orci et al., 1986). Generally, insulin is well-known as an important regulator in 
glucose homeostasis. In high glucose condition insulin production is increased, 
increasing in insulin levels ultimately enhances for glucose uptake and glycogen 
synthesis activities, and inhibits glycogenolysis and gluconeogenesis process, thus 
preserving a normoglycaemia status in humans. Besides, insulin also exerts in a 
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number of other important metabolic effects. For example, it controls the genes 
expression involved in lipid metabolism in the muscle and adipose tissues, amino 
acid uptake and cell growth, development and survival (Rhodes and White, 2002).  
Maintenance of normoglycaemia needs a strong co-ordinated control of both 
insulin action and secretion. Because loss of glycaemic control usually causes 
reduction in both insulin action (example is peripheral insulin resistance) and insulin 
secretion (example is β-cell dysfunction) activities. Insulin action is mediated 
through a multi-component signalling complex that is strongly conserved across a 
wide range of species. Binding of insulin to its receptor activates tyrosine kinase, 
resulting in autophosphorylation of tyrosine residues on the receptor β-subunit and 
leads to phosphorylation of insulin receptor substrate (IRS) proteins. This IRS 
protein importantly trigger multiple downstream signalling molecules, such as 
phosphatidylinositol 3-kinase (PI3K). In skeletal muscle and adipose tissues, 
activation of the PI3K pathway promotes glucose utilization by regulating the 
expression or subcellular localization of glucose transporters (GLUT) and stimulates 
the glucose storage as glycogen or fat. Whereas, in pancreatic β cells, the PI3K 
cascade possibly promotes survival of β cells (Rhodes and White, 2002).  
Glucose is the main regulator of insulin secretion. Briefly, exposure to 
glucose elevates the ATP:ADP ratio and leads to closure of ATP-sensitive potassium 
channels. This in turn causes membrane depolarization and consequently stimulates 
the opening of the voltage-dependent Ca2+ (calcium) channels. The resultant Ca2+ 
influx leads to increased cytosolic Ca2+ concentrations and results in exocytosis of 
insulin secretory particles from the storage granule. Figure 2.1 shows the 
mechanisms of insulin secretion from β-cells that are located in the islets of 
Langerhans in the pancreas in response to blood glucose changes. 
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Figure 2.1 Glucose-stimulated insulin secretions in pancreatic β-cells at the islets of 
Langerhans in the pancreas. Transportation of glucose into β cell increases the 
ATP:ADP ratio, thus triggers  the opening the calcium channels through closure of 
ATP-sensitive potassium channels. This allows the flow inward of Ca2+ (calcium 
ions) into the β cells and yields in exocytose of insulin secretion from storage 
granules (modified figure from (De Leon and Stanley, 2007)) 
 
 
2.3.3  Insulin resistance  
Insulin resistance (IR) is a state where body secretes insulin but does not use 
it properly (NIDDK, 2008). Low insulin sensitivity or insulin resistance always been 
noticed in CVD such as diabetes, metabolic syndrome, obesity and stroke 
(McFarlane et al., 2001, Ginsberg, 2000). Fasting insulin level is capable of 
determining insulin resistance (Laakso, 1993). Abnormalities in insulin signalling in 
the muscle, adipose tissue, liver and pancreas lead to IR and β-cell dysfunction in 
T2D patients (Rhodes and White, 2002) 
ATP:ADP 
      Ca2+ 
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A number of methods have been developed to measure insulin sensitivity or 
resistance which ranges from complex procedures to simple indices (Muniyappa et 
al., 2008, Borai et al., 2011). The measurement of glucose clamp method (DeFronzo 
et al., 1979) is a gold standard for direct measurement of insulin sensitivity. It is a 
steady-state technique which needs a constant insulin infusion in order to measure 
the sensitivity of insulin action. However, this technique is time consuming, 
expensive and requires expertise to handle, while not suitable to be appllied in large 
samples. A quite simple, non-invasive alternative to the clamp method is the 
homeostasis model assessment (HOMA). A simple index of insulin resistance is 
categorized as an index that does not need the intravenous administration of 
exogenous insulin or glucose. It can be assessed either from a fasting specimen alone 
or fasting specimen along with other blood samples taken following an oral glucose 
load. Simple indixes, not like dynamic techniques which does not demand on steady 
state conditions (Borai et al., 2011). Besides, using the simple indexes required 
inexpensive spending because it simply to use in nearly every study’s setting 
including epidemiological studies, large clinical trials, clinical research 
investigations, and clinical practice (Muniyappa et al., 2008). The simple index used 
in our present study is homeostasis model assessment derived for insulin resistance 
(HOMA-IR) (Matthews et al., 1985). HOMA-IR was first developed by Matthews et 
al. in 1985 (Matthews et al., 1985) and has widely been used in estimation of insulin 
resistance. Moreover, HOMA-IR has a reasonable correlation against glucose clamp 
method in several different population studies (Radziuk, 2000, Wallace et al., 2004).  
Barnoya and Glantz (2005) concluded SHS exposure might also lead to an 
increase in heart disease by increasing insulin resistance (Barnoya and Glantz, 2005). 
Previous studies have extensively discussed the relationship between passive 
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smoking and the incidence of diabetes (Hayashino et al., 2008b, Kowall et al., 2010, 
Houston et al., 2006). For example, the significance of diabetes cases were reported 
in those exposed to SHS at workplace over 4 years (Hayashino et al., 2008a). 
Similarly, the cumulative 7 year incidence of diabetes was lower in non-SHS (7.1%) 
compared to SHS (11.4%) (Kowall et al., 2010). A cohort study showed that the 15 
year prevalence of glucose intolerance was highest in non-smokers with exposure to 
SHS compared to non exposure (Houston et al., 2006). Furthermore, Henkin et al 
(1999) also reported that the level of insulin sensitivity is lower in people exposed to 
tobacco smoke than those who were free from exposure (Henkin et al., 1999).  
 
2.3.4 Non-estrified fatty acid (NEFA) 
Non-esterified fatty acids were recognized in 1950s by Robert Gordon 
(Gordon and Cherkes, 1956). Non-esterifies ("free" or unsaturated) fatty acids 
(NEFAs) is also known as free fatty acids (FFAs). NEFA are important energy 
source for several organs and also associated in promoting insulin resistance in the 
human body. Higher level of NEFA usually causes pathogenesis of metabolic 
disturbances such as insulin resistance and metabolic syndrome (Stich and Berlan, 
2004). Adipose tissue releases fatty acids for the muscle and liver by hydrolysis of 
triacylglycerol, through the action of the hormone-sensitive lipase (HSL) enzyme 
and other lipases, to liberate NEFA into the plasma (Frayn et al., 2006, Thompson et 
al., 2012). 
The half-life of plasma NEFA is about 3 minutes before being secreted into 
the urine (Bonadonna et al., 1990). The plasma NEFA level varies considerably with 
time. For example, in overnight fasting state NEFA ranges about 300-600 µmol/L 
and increased approximately to 1300 µmol/L after 72 hours fasting (Frayn et al., 
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1996). During the fasting state, hydrolysis (lipolysis) of stored (intracellular) 
triacylglycerol occurrs in the adipocytes to liberate NEFA into the circulation (Frayn 
et al., 1996). After taking any meal containing carbohydrates, plasma NEFA 
concentrations significantly decrease because carbohydrates stimulate insulin release 
(Dole, 1956).  
Smoking is responsible for NEFA increase and glycerol fluxes due to 
nicotine induced lypolysis. Early on 1961, a study by Kershbaum et al. revealed that 
a minimum of two cigarettes smoking elevate the FFA level (Kershbaum et al., 
1961). Nicotine may induce lipolysis by stimulating the release of catecholamines 
(norepinephrine and epinephrine) from the sympathetic nervous system. These 
catecholamines rapidly act on adipose tissues and lipolysed triglycerides to liberate 
NEFA into the circulation (Andersson and Arner, 2001, Cryer et al., 1976b).     
An increase in NEFA leads to metabolic syndrome and insulin resistance in 
humans (Stich and Berlan, 2004). NEFA that is produced from the adipose tissue 
enhances the level of triglycerides, glucose and secretion of very low-density 
lipoprotein (VLDL) in the liver, as well as it decreases insulin sensitivity in the 
muscle through inhibiting insulin-mediated glucose uptake (Eckel et al., 2005).  
Previous studies recognized that NEFA level is higher in obese (Opie and Walfish, 
1963) and insulin resistant subjects (Jouven et al., 2001). This is because obesity is 
linked with increased accumulation of adipose tissue mass; enhanced triglycerides 
(TG) production, thereby increased NEFA levels. Otherwise, excess NEFA leads to 
acute hyperinsulineamia by inhibiting insulin binding to hepatocytes, hence reduces 
approximately 40% of insulin secretion (Svedberg et al., 1990, Karpe et al., 2011). 
In addition, there are studies showing that higher level of NEFA is related with 
coronary heart disease incidences (Frayn et al., 1996, Jouven et al., 2001).  
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2.3.5 8-isoprostane  
Oxidative stress is defined as a imbalance between production of free radicals 
and antioxidant defences, causing oxidation of proteins, lipids and DNA which 
potentially impair cellular function (Burke and Fitzgerald, 2003). Oxidative stress is 
linked with many acute and chronic diseases such as lung disease, CVD, 
neurodegenerative disease, cancer and aging process (Montuschi et al., 2004). 
8-isoprostane, also referred to F2-isoprostane, is a prostaglandin-like 
compound derived from the peroxidation of arachidonic acid (lipid). Over the past 
decade, 8-isoprostane has appeared as the “gold standard” to determine of oxidative 
stress in vivo and has been applied broadly to assess lipid peroxidation (Morrow, 
2005). Measurement of 8-isoprostane has several advantages over other markers 
(Montuschi et al., 2004); 1) specific products of lipid peroxidation, 2) chemically 
stable compound, 3) formed in vivo, 4) present in detectable amounts in all normal 
tissues and biological fluids, thus allowing definition of a normal range, 5) not 
affected by lipid content in the diet (Gopaul et al., 2000, Richelle et al., 1999) and 6) 
their levels increase significantly in animal models of oxidant injury. Urinary 8-
isoprostane concentration is reportedly unaffected by the daily variability in healthy 
subjects (Montuschi et al., 2004). 
Gas choromatography-mass spectrophotometer (GCMS) is the gold standard 
method for measuring 8-isoprostane, but it is time consuming and unreliable to apply 
in large sample population as our present study.  Thus, currently an in vivo enzyme 
immunoassay (EIA) has been developed and reliable to use in large sample study 
population. There is evidence that isoprostanes measured by EIA has a good 
correlation with GCMS (r=0.99) (Devaraj et al., 2001, Wang et al., 1995). Moreover, 
serum isoprostane has an advantage over urinary isoprostane, because urinary 
